From: Should we look for silent pulmonary embolism in patients with deep venous thrombosis?
All | S-PE | No S-PE | OR | p | |
---|---|---|---|---|---|
Age (yr) | 61.5 (19) | 61.2 (19.4) | 60.1 (18.8) | 1.12 (-6.83-9.07) | 0.78 |
Males | 59 (57%) | 42 (61.8%) | 17 (48.6%) | 0.59 (0.26-1.13) | 0.22 |
Risk factors | |||||
Venous* | 22 (21.4%) | 13 (19.1%) | 9 (25.7%) | 0.68 (0.26-1.80) | 0.45 |
Hypertension | 46 (44.7%) | 30 (44.1%) | 16 (45.7%) | 0.94 (0.41-2.13) | 1 |
Type 2 diabetes | 18 (17.5%) | 13 (19.1%) | 5 (14.3%) | 1.41 (0.46-4.36) | 0.60 |
Dyslipidemia | 30 (29.1%) | 19 (27.2%) | 11 (31.4%) | 0.84 (0.35-2.06) | 0.82 |
DVT location | |||||
Ileo-femoral | 92 (89.3%) | 62 (91.2%) | 30 (85.7%) | 0.58 (0.17-2.56) | 0.50 |
Poplitea | 11 (10.7%) | 6 (8.8%) | 5 (14.3%) | ||
DVT lateratity | |||||
Right leg | 46 (44.7%) | 28 (41.2%) | 18 (51.4%) | 1.5 (0.66-3.43) | 0.40 |
Left leg | 57 (55.3%) | 40 (58.8%) | 17 (48.6%) | ||
Bilateral | 5 (4.9%) | 5 (7.4%) | 0 | 0.64 (0.55-0.74) | 0.16 |